Stephan Arni
Overview
Explore the profile of Stephan Arni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Iskender I, Arni S, Maeyashiki T, Citak N, Sauer M, Rodriguez J, et al.
J Thorac Cardiovasc Surg
. 2020 Mar;
161(2):e109-e121.
PMID: 32201002
Objective: Improvement in ex vivo lung perfusion protocols could increase the number of donors available for transplantation and protect the lungs from primary graft dysfunction. We hypothesize that perfusate adsorption...
12.
Jang J, Janker F, De Meester I, Arni S, Borgeaud N, Yamada Y, et al.
Carcinogenesis
. 2019 Jan;
40(2):324-334.
PMID: 30698677
CD26/dipeptidyl peptidase 4 (DPP4) is a transmembrane protein which is expressed by various malignant cells. We found that the expression of CD26/DPP4 was significantly higher in lung adenocarcinoma samples in...
13.
Arni S, de Wijn R, Garcia-Villegas R, Bitanihirwe B, Caviezel C, Weder W, et al.
Anal Biochem
. 2018 Feb;
547:77-83.
PMID: 29408474
The use of optimal cutting temperature (OCT) medium has served to improve the long-term preservation of surgical tissue specimens. Unfortunately, the presence of polymers in OCT has been found to...
14.
Yamada Y, Iskender I, Arni S, Hillinger S, Cosgun T, Yu K, et al.
J Surg Res
. 2017 Oct;
218:341-347.
PMID: 28985871
Background: We have shown the beneficial effects of N-acetylcysteine (NAC) on posttransplant lung function, when both donor and recipient were pretreated intravenously. However, systemic treatment of multiorgan donors may not...
15.
Arni S, Le T, de Wijn R, Garcia-Villegas R, Dankers M, Weder W, et al.
Oncotarget
. 2017 Oct;
8(40):68599-68613.
PMID: 28978141
Despite constant improvement in existing therapeutic efforts, the overall survival rate of lung cancer patients remains low. Enzyme activities may identify new therapeutically targetable biomarkers and overcome the marked lack...
16.
Cosgun T, Iskender I, Yamada Y, Arni S, Lipiski M, van Tilburg K, et al.
Eur J Cardiothorac Surg
. 2017 Sep;
52(1):171-177.
PMID: 28874022
Objectives: Ex vivo lung perfusion (EVLP) is not only used to assess marginal donor lungs but is also used as a platform to deliver therapeutic agents outside the body. We...
17.
Cytokine filtration modulates pulmonary metabolism and edema formation during ex vivo lung perfusion
Iskender I, Cosgun T, Arni S, Trinkwitz M, Fehlings S, Yamada Y, et al.
J Heart Lung Transplant
. 2017 Jun;
PMID: 28587802
Background: Ex vivo lung perfusion (EVLP) has improved the process of donor lung management. Cytokine accumulation during EVLP has been shown to correlate with worse outcome after lung transplantation. Our...
18.
Meerang M, Berard K, Felley-Bosco E, Lauk O, Vrugt B, Boss A, et al.
Mol Cancer Ther
. 2016 Feb;
15(5):1095-105.
PMID: 26839306
An autocrine-driven upregulation of the Hedgehog (Hh) signaling pathway has been described in malignant pleural mesothelioma (MPM), in which the ligand, desert Hh (DHH), was produced from tumor cells. However,...
19.
Meerang M, Boss A, Kenkel D, Broggini-Tenzer A, Berard K, Lauk O, et al.
Eur J Cardiothorac Surg
. 2014 Oct;
47(1):e34-41.
PMID: 25344922
Objectives: An orthotopic rat tumour recurrence model for malignant pleural mesothelioma (MPM) provides clinical similarity to patients and is useful for drug testing combined with surgical intervention. Importantly, a reliable...
20.
Inci I, Hillinger S, Arni S, Kaplan T, Inci D, Weder W
J Surg Res
. 2013 May;
184(2):1143-9.
PMID: 23706563
Background: We tested whether an injured lung graft from category-3 donation after cardiac death donor could be reconditioned with an ex vivo lung perfusion (EVLP) system by intrabronchial diluted surfactant...